Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Mechanistic insights from sequential combination therapy with a sodium glucose co-transporter-2 inhibitor and a dipeptidyl peptidase-4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin

Authors:	Sumie Okahata MD Kentaro Sakamoto MD Takako Mitsumatsu MD Yuko Kondo MD Shoji Tanaka MD Teruo Shiba MD

Affiliation:	Division of Diabetes and Metabolism, Toho University Ohashi Medical Center, Tokyo, Japan

Abstract:

Keywords:	antidiabetic drug canagliflozin dipeptidyl peptidase-4 inhibitor glucagon